Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Bonhams 1793 Limited in connection with its acquisition of Bukowski
Mandate

Vinge advises Bonhams 1793 Limited in connection with its acquisition of Bukowski

January 11, 2022 M&A

Vinge has advised Bonhams 1793 Limited, an international auction house with its head office in London, and a portfolio company of Epiris LLP, in connection with its acquisition of Bukowski Auktioner Aktiebolag (”Bukowski”).

Bukowski is an auction house within art and antiquities with its head office in Berzelii Park in Stockholm. The company also has a Finnish Subsidiary, Bukowski Oy. Through the acquisition, Bonhams will extend its geographical presence in Europe.

Vinge’s team consisted of, among others, Christina Kokko, Isabelle Wållgren, Hannah Kajlinger, Christa Anttila, Vilhelm Rondahl and Ellen Åkerdahl Flygt (M&A), Anton Sjökvist and Caroline Krassén (Financial Services), Tove Lövgren Frisk (Compliance), Karl-Hugo Engdahl (GDPR, IT), Ulf Pyk (Real Estate), Karolina Fuhrman and Isabell Nielsen (Corporate Commercial), Arvid Axelryd (IP), Emil Lindvall and Gustav Lindgren (Employment) as well as Sara Dahlros Sköld (VDR).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025